Patent · US Active

Substituted fused heterocyclic C-glycosides

US7482330B2 · kind B2 · utility

1Cited by

17References

15Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Philip Rybczynski · Somerville, US
Maud Urbanski · Flemington, US
Xiaoyan Zhang · Lexington, US

Key dates

Filing date	Jun 15, 2006
Grant date	Jan 27, 2009
Priority date	—
Expiry date	Jul 21, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to substituted fused heterocyclic C-glycosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.